Vanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by Analysts at StockNews.com
StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald raised their price target on shares of Vanda Pharmaceuticals from $11.00 to $13.00 and gave the stock an “overweight” rating in a research […]
25 Oct 08:56 · The Cerbat Gem